Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-26

Clinical Trial Update: Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports results for treatment-naive HIV-1 adults treated with regimens containing Nevirapine or Atazanavir/Ritonavir plus Emtricitabine/T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATAZANAVIR (atazanavir)
  • Emtricitabine (Emtricitabine)
  • NEVIRAPINE (nevirapine)
  • Ritonavir (Ritonavir)
  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2012-03-26